Table 2.
Characteristic | Patient (N=123) | |
Age (years), median (IQR) | 65 (56-72) | |
Gender (female), n (%) | 66 (57) | |
Distance from hospital (km), median (range) | 12 (4-138) | |
AKPSa (0-100), median (IQR) | 70 (70-80) | |
Type of cancer, n (%) | ||
|
Breast | 39 (32) |
|
Lower gastrointestinal | 7 (6) |
|
Prostate | 8 (7) |
|
Gynecological | 6 (5) |
|
Multiple myeloma | 17 (14) |
|
Lymphoma | 10 (8) |
|
Leukemia | 10 (8) |
|
Lung | 7 (6) |
|
Other | 19 (15) |
Cancer stage, n (%)b | ||
|
Early | 40 (33) |
|
Advanced | 74 (60) |
|
Recurrent | 7 (6) |
Current treatment received, n (%) | ||
|
Chemotherapy | 69 (56) |
|
Radiotherapy | 18 (15) |
|
Immunotherapy | 5 (4) |
|
Stem cell transplant | 4 (3) |
|
Hormone therapy | 6 (5) |
|
Other | 2 (2) |
|
None | 19 (15) |
aAKPS: Australian Karnofsky Performance Status.
bCancer stage not available for 2 participants.